Propranolol-magnesium aluminum silicate complex dispersions and particles: Characterization and factors influencing drug release

International Journal of Pharmaceutics

Volumn 383, Issue 1-2, 2010, Pages 106-115

  Rojtanatanya, Sarasit ^a   Pongjanyakul, Thaned ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Complexes; Drug release; Magnesium aluminum silicate; Molecular interaction; Propranolol

Indexed keywords

ALUMINUM MAGNESIUM SODIUM SILICATE; BUFFER; DRUG CARRIER; PHOSPHATE; PROPRANOLOL;

ACIDITY; ADSORPTION; ARTICLE; CATION EXCHANGE; COMPLEX FORMATION; CONTROLLED STUDY; DISPERSION; DRUG DIFFUSION; DRUG RELEASE; DRUG STRUCTURE; FLOCCULATION; HYDROGEN BOND; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTERCALATION COMPLEX; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARTICLE SIZE; PH; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; ZETA POTENTIAL;

ALUMINUM COMPOUNDS; DELAYED-ACTION PREPARATIONS; MAGNESIUM COMPOUNDS; PARTICLE SIZE; PROPRANOLOL; SILICATES;

EID: 70449530523     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.09.016     Document Type: Article

References (27)

1. Aguzzi C., Cerezo P., Viseras C., and Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 36 (2007) 22-36
2. Alexandre M., and Dubois P. Polymer-layered silicate nanocomposites: preparation, properties and uses of a new class of materials. Mater. Sci. Eng. 28 (2000) 1-63
3. Benna M., Kbir-Ariguib N., Magnin A., and Bergaya F. Effect of pH on rheological properties of purified sodium bentonite suspensions. J. Colloid Interface Sci. 218 (1999) 442-455
4. Bhaskar R., Murthy R.S.R., Miglani B.D., and Viswanathan K. Novel method to evaluate diffusion controlled release of drug from resinate. Int. J. Pharm. 28 (1986) 59-66
5. Dollery S.C. Therapeutic Drugs (1991), Churchill Livingstone, Edinburgh pp. P272-P278
6. Gates W.P., Komadel P., Madejová J., Bujdák J., Stucki J.W., and Kirkpatrick R.J. Electronic and structural properties of reduced-charge montmorillonite. Appl. Clay Sci. 16 (2000) 257-271
7. Gil E.C., Colarte A.I., Bataille B., Pedraz J.L., Rodríguez F., and Heinämäki J. Development and optimization of a novel sustained-release dextran tablet formulation for propranolol hydrochloride. Int. J. Pharm. 317 (2006) 32-39
8. Gupta M.K., Vanwert A., and Bogner R.H. Formation of physical stable amorphous drugs by milling with Neusilin. J. Pharm. Sci. 92 (2003) 536-551
9. Heyrovska, R., 2009. Golden sections of inter-atomic distances as exact ionic radii of atoms. Nature Precedings (http://hdl.handle.net/10101/npre.2009.2929.1).
10. Hoch M., and Bandara A. Determination of the adsorption process of tributyltin (TBT) and monobutyltin (MBT) onto kaolinite surface using Fourier transform infrared (FTIR) spectroscopy. Colloids Surf. A 253 (2005) 117-124
11. Joshi G.V., Kevadiya B.D., Patel H.A., Bajaj H.C., and Jasra R.V. Montmorillonite as a drug delivery system: intercalation and in vitro release of timolol maleate. Int. J. Pharm. 374 (2009) 53-57
12. Kibbe H.A. Handbook of Pharmaceutical Excipients. 3rd ed. (2000), American Pharmaceutical Association, Washington pp. 295-298
13. Martin A. Physical Pharmacy. 4th edition (1993), Lea&Febiger, Philadelphia pp. 251-283
14. McGinity J.W., and Lach J.L. Sustained-release application of montmorillonite interaction with amphetamine sulfate. J. Pharm. Sci. 66 (1977) 63-66
15. Murray H.H. Traditional and new applications for kaolin, smectite, and palygorskite: a general overview. Appl. Clay Sci. 17 (2000) 207-221
16. Ni Z., Xing F., Wang P., and Cao G. Synthesis, characterization and release of curcumin-intercalated Mg-Al-layered double hydroxides. Appl. Clay Sci. 40 (2008) 72-80
17. Nunes C.D., Vaz P.D., Fernandes A.C., Ferreira P., Romão C.C., and Calhorda M.J. Loading and delivery of sertraline using inorganic micro and mesoporous materials. Eur. J. Pharm. Biopharm. 66 (2007) 357-365
18. Paker-Leggs S., and Neau S.H. Pellet characteristics and drug release when the form of propranolol is fixed as moles or mass in formulations for extruded and spheronized Carbopol-containing pellets. Int. J. Pharm. 369 (2009) 96-104
19. Park J.K., Choy Y.B., Oh J., Kim J.Y., Hwang S., and Choy J. Controlled release of donepezil intercalated in smectite clays. Int. J. Pharm. 359 (2008) 198-204
20. Pongjanyakul T., Khunawattanakul W., and Puttipipatkhachorn S. Physicochemical characterizations and release studies of nicotine-magnesium aluminum silicate complexes. Appl. Clay Sci. 44 (2009) 242-250
21. ®SR or hydroxy propyl methyl cellulose. AAPS Pharm. Sci. Technol. 9 (2008) 577-582
22. Sánchez-Martin M.J., Sánchez-Camazano M., Vicente-Hernández M.T., and Dominguez-Gil A. Interaction of propranolol hydrochloride with montmorillonite. J. Pharm. Pharmacol. 33 (1981) 408-410
23. Sinha Ray S., Yamada K., Okamoto M., Ogami A., and Ueda K. New polylactide/layered silicate nanocomposites: 3. High performance biodegradable materials. Chem. Mater. 15 (2003) 1456-1465
24. Suksri H., and Pongjanyakul T. Interaction of nicotine with magnesium aluminum silicate at different pHs: characterization of flocculate size, zeta potential and nicotine adsorption behavior. Colloids Surf. B. 65 (2008) 54-60
25. Trikeriotis M., and Ghanotakis D.F. Intercalation of hydrophilic and hydrophobic antibiotics in layered double hydroxides. Int. J. Pharm. 332 (2007) 176-184
26. Velde B. Introduction to Clay Minerals (1992), Chapman & Hall, London pp. 12-36
27. Viseras C., Aguzzi C., Cerezo P., and Lopez-Galindo A. Uses of clay minerals in semisolid health care and therapeutic products. Appl. Clay Sci. 36 (2007) 37-50